Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort
Cardiovascular Research · 06.11.2026 · 122 (15) · 2063-2065
DOI: 10.1093/cvr/cvag181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 31.08.2026. Verfasst von Susan K Keen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hypertrophic Cardiomyopathy Center, Heart, Vascular and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J1-5, Cleveland Clinic, Clevel…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Contrast Media, Magnetic Resonance Imaging, Cine, Myocardium. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Aims
Extensive late gadolinium enhancement (LGE) is recognized in contemporary hypertrophic cardiomyopathy (HCM) risk assessment, but the prognostic value of lower quantitative thresholds remains debated. We aimed to evaluate whether quantitative LGE provides independent and incremental prognostic information beyond established clinical and phenotypic risk markers. Methods and results This large contemporary cohort included 3035 patients (median age 58 years, 57% men); 56% had LGE, including 242 (8%) with LGE > 10%. Most patients have obstructive hypertrophic cardiomyopathy (71%), 1498 (69%) of which subsequently underwent septal reduction therapy at a median of 43 days [interquartile range (IQR) 5–107) from the cardiac magnetic resonance (CMR) date (1485 myectomies and 13 alcohol septal ablations). Over a median of 8.8 years, 331 (11%) primary endpoints occurred [295 cardiovascular deaths (9.7%) and 36 appropriate implantable cardioverter–defibrillator discharges (1.3%)]. On multivariable Cox proportional hazards analysis [adjusted for standard clinical and CMR variables, higher %LGE (1.05 per 1% increase, 95% confidence interval 1.03–1.06; P < 0.001)] was associated with primary events. Compared with no LGE, LGE ≥10% was associated with higher risk of the composite endpoint.
Conclusion
In this large contemporary HCM cohort, quantitative LGE was independently associated with long-term adverse outcomes. LGE ≥10% identified patients at significantly higher risk, and incorporation of LGE improved discrimination beyond ESC and AHA/ACC risk assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hypertrophic Cardiomyopathy Center, Heart, Vascular and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J1-5, Cleveland Clinic, Cleveland, OH 44195, USA.
ORCID-Profile: Susan K Keen, Stuti Shah, Hesham Sheashaa, Mohammed Abusafia, Shada Jadam, Simrat Kaur, Andrew Gaballa, Susan Ospina, Jay Ramchand, Zoran B Popovic, Nicholas G Smedira, Paul Schoenhagen, Bo Xu, Milind Y Desai
Zitieren
APA
Keen, S. K., Shah, S., Sheashaa, H., Abusafia, M., Jadam, S., Kaur, S., Gaballa, A., Ospina, S., Rutkowski, K., Ramchand, J., Popovic, Z. B., Thamilarasan, M., Smedira, N. G., Schoenhagen, P., Xu, B., Bolen, M., & Desai, M. Y. (2026). Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort. Cardiovascular Research, 122(15), 2063-2065. https://doi.org/10.1093/cvr/cvag181
Vancouver
Keen SK, Shah S, Sheashaa H, Abusafia M, Jadam S, Kaur S, et al. Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort. Cardiovascular Research. 2026;122(15):2063-2065. doi:10.1093/cvr/cvag181
BibTeX
@article{Keen2026,
author = {Keen, Susan K and Shah, Stuti and Sheashaa, Hesham and Abusafia, Mohammed and Jadam, Shada and Kaur, Simrat and Gaballa, Andrew and Ospina, Susan and Rutkowski, Katy and Ramchand, Jay and Popovic, Zoran B and Thamilarasan, Maran and Smedira, Nicholas G and Schoenhagen, Paul and Xu, Bo and Bolen, Michael and Desai, Milind Y},
title = {Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {15},
pages = {2063--2065},
doi = {10.1093/cvr/cvag181}
}
EUVIMED